Rosacea's 4 Types: Accurate Diagnosis & Evidence-Based Treatment

This is an English adaptation of a clinical article Dr. SangYoul Yun — board-certified dermatologist and Medical Director of Delight Dermatology in Gangnam, Seoul — originally published in Korean. Read the Korean original on Naver. It has been restructured and translated for international readers; all references are the author's own.

"My face keeps flushing. It looks a bit like acne, but the acne medication isn't working." After the summer UV season, this is one of the most common stories I hear in clinic. Very often the real diagnosis is not simple flushing or acne — it is rosacea, a chronic inflammatory skin disease that is frequently missed in Korea.

Rosacea affects roughly 5% of people worldwide,¹ yet it is often mislabelled as "acne" or "redness" and treated incorrectly. The reason it is so hard to diagnose is that a single disease shows up as four different clinical phenotypes. In 2017 the global ROSacea COnsensus (ROSCO) panel consolidated 20 years of data and moved the international standard from a subtype model to a phenotype model.^2,3

The four phenotypes of rosacea

Rosacea is one inflammatory continuum expressed as four phenotypes
Type	Name	Hallmark
Type 1	Erythematotelangiectatic (ETR)	Persistent central redness with visible vessels
Type 2	Papulopustular (PPR)	Recurrent acne-like papules and pustules
Type 3	Phymatous	Skin thickening (e.g. of the nose)
Type 4	Ocular	Eye involvement — dryness, irritation

Crucially, these are not separate diseases — they are one inflammatory continuum,⁴ so several phenotypes can appear together and treatment has to be matched to the combination.

ROSCO 2017 diagnostic criteria

Because rosacea is easy to misdiagnose, the international panel set clear criteria:^2,3

Diagnostic features (either one alone confirms rosacea): phymatous changes; or centrofacial persistent erythema that periodically intensifies.
Major features (two or more confirm rosacea): flushing / transient erythema; papules and pustules; telangiectasia; ocular manifestations.
Secondary features (supportive): burning / stinging; edema; dryness and scaling.

Four triggers — why summer is the danger season

Rosacea is fundamentally about chronic control of an inflammatory state, so knowing and avoiding triggers matters as much as any procedure.⁵ The four classic triggers are UV exposure, heat / temperature change, spicy food / alcohol, and emotional stress.⁶ Summer exposes you to several at once: UV drives up cathelicidin and matrix metalloproteinases (MMPs), fuelling vessel dilation and inflammation, while moving between air-conditioning and outdoor heat provokes rapid vascular responses.⁶ A personal trigger diary is part of the treatment, not an afterthought.

Phenotype-matched, evidence-based treatment

The options below draw on the 2019 van Zuuren systematic review (152 studies, 20,944 patients).⁷ Evidence strength is shown as [H] high / [M] moderate / [L] low.

① Erythematotelangiectatic (ETR) — target the vessels

Vascular lasers — PDL, Nd:YAG, IPL [M] — are the core treatment for persistent redness and visible vessels; topical metronidazole [M] supports control. (Topical brimonidine was used for its α-adrenergic vasoconstriction but has been discontinued.) In clinic we deliver this through Vbeam vascular laser and Laser Genesis.

② Papulopustular (PPR) — anti-inflammatory / antimicrobial

First line is topical ivermectin 1% plus oral doxycycline [H], which reduces Demodex and inflammation and lowers recurrence. Second line: azelaic acid 15% [H], metronidazole 0.75% [H], isotretinoin for severe cases [H]. Important: benzoyl peroxide — a standard acne agent — can worsen rosacea, which is exactly the harm done when it is misdiagnosed as acne.

③ Phymatous — restore the structure

First line is ablative laser — CO₂ or Er:YAG [L] — to precisely re-contour thickened tissue; isotretinoin can help early or preventively [M], with surgery reserved for advanced cases [L].

④ Ocular — co-manage with ophthalmology

First line is oral doxycycline plus omega-3 [M] to inhibit MMPs and calm inflammation; second line includes cyclosporine 0.05% eye drops [M], artificial tears and warm compresses [M], with ophthalmology co-management the standard [H].

Barrier repair — when drugs and lasers aren't enough

An axis that is easy to miss is the skin barrier. Rosacea skin sits in a vicious cycle: an impaired barrier raises transepidermal water loss (TEWL), which increases vulnerability to triggers, which drives more inflammation and redness. If you calm the redness with drugs and lasers but leave the barrier weak, it keeps relapsing. Three barrier-focused adjuncts we use:

LDM (dual-frequency ultrasound) — micro-vibration that calms acute flushing and strengthens the barrier with no downtime. A 2021 study (Kim et al., Journal of Clinical Medicine) reported statistically significant reductions in TEWL and erythema index over four weekly sessions.
PRP (platelet-rich plasma) — growth factors (PDGF, TGF-β, VEGF) that support collagen and barrier repair; useful in refractory or relapsing rosacea (Ghoz et al. 2021, Dermatologic Therapy; Pang et al. 2025, J Cosmet Dermatol).
Laser Genesis (low-fluence 1064 nm Nd:YAG) — diffuse dermal heating that improves background redness without damaging the barrier, making it safer for sensitive skin than higher-energy settings. PDL remains the gold standard.

The principle: drugs and vascular lasers "put out the fire," while barrier repair keeps it from reigniting. In practice we sequence them — acute phase (calm inflammation + LDM), stable phase (vascular laser), maintenance (regular LDM, and PRP where refractory).

Myths vs clinical facts

"All facial redness is rosacea." No — differential diagnosis from simple flushing, seborrheic dermatitis, acne and contact dermatitis is essential.
"Acne medication will fix it." Antibiotics help the papulopustular type, but standard acne agents (benzoyl peroxide, strong retinoids) can aggravate rosacea skin.
"Cold water calms it." The relief is momentary; the sudden temperature change is itself a trigger. Lukewarm water is preferred.
"One procedure cures it." Rosacea is a chronic condition to be managed, not cured — long-term trigger control plus maintenance is the standard.

How we approach rosacea at Delight Dermatology

Accurate differential diagnosis first (ROSCO criteria + dermoscopy), phenotype-based individualized protocols, vascular lasers for persistent redness, strong trigger education with a personal diary, and long-term maintenance aimed at control rather than a "cure." With rosacea, accurate diagnosis decides most of the outcome — because misdiagnosis as acne is one of the classic ways it gets worse.

Bottom line: rosacea is one chronic disease with four faces. Accurate diagnosis is where management begins — especially after the summer UV season. If you have facial redness, recurring acne-like lesions, or eye symptoms, don't write it off as simple flushing.

References

Medical disclaimer. This article is general information and does not replace individual consultation. Rosacea is a chronic condition where differential diagnosis matters; diagnosis and treatment should be decided after an in-person consultation with a dermatologist. Prescription medicines (antibiotics, ivermectin, isotretinoin, etc.) require a doctor's care, and ocular symptoms may need ophthalmology co-management.